1. Home
  2. YOOV vs KRRO Comparison

YOOV vs KRRO Comparison

Compare YOOV & KRRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Concorde International Group Ltd Class A Ordinary Shares

YOOV

Concorde International Group Ltd Class A Ordinary Shares

N/A

Current Price

$0.52

Market Cap

158.7M

ML Signal

N/A

Logo Korro Bio Inc.

KRRO

Korro Bio Inc.

HOLD

Current Price

$11.47

Market Cap

187.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
YOOV
KRRO
Founded
N/A
2014
Country
Singapore
United States
Employees
109
N/A
Industry
Diversified Commercial Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
158.7M
187.9M
IPO Year
2025
2019

Fundamental Metrics

Financial Performance
Metric
YOOV
KRRO
Price
$0.52
$11.47
Analyst Decision
Buy
Analyst Count
0
12
Target Price
N/A
$34.80
AVG Volume (30 Days)
3.4M
293.6K
Earning Date
N/A
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$6,392,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
181.46
52 Week Low
$0.36
$5.20
52 Week High
$1.11
$55.89

Technical Indicators

Market Signals
Indicator
YOOV
KRRO
Relative Strength Index (RSI) 50.18 39.04
Support Level $0.44 $10.32
Resistance Level $0.79 $14.78
Average True Range (ATR) 0.16 1.15
MACD -0.02 -0.31
Stochastic Oscillator 19.04 5.40

Price Performance

Historical Comparison
YOOV
KRRO

About YOOV Concorde International Group Ltd Class A Ordinary Shares

Concorde International Group Ltd is an integrated security services provider that combines physical manpower and technology to deliver effective security solutions. The company offers a range of services to enhance security and safety: (1) i-Guarding Services; (2) Man-Guarding Services; and (3) Consultancy and Training Services. Its i-Guarding Services leverages technology to increase efficiency, with a mobile platform and cluster aggregation model of a higher skillset workforce. It has two operating segments, which are (i) security services; and (ii) training school. The Majority revenue is generated from Security Services.

About KRRO Korro Bio Inc.

Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability. The company operates and manages its business as one reportable segment and one operating segment, which is the business of discovering, developing and commercializing therapies derived from or incorporating its RNA-editing technology.

Share on Social Networks: